World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
65
Citations
34798
World Ranking
2457
National Ranking
994

Overview

George Kuo is affiliated with Novartis in the United States. Their research primarily falls within the field of Medicine, with a strong focus on Nephrology. Other notable subfields of their work include Surgery, Epidemiology, Pulmonary and Respiratory Medicine, and Emergency Medicine.

The main topics covered by Kuo's research involve Acute Kidney Injury (AKI) and its progression, Dialysis and Renal Disease Management, and Chronic Kidney Disease in relation to diabetes. Additional topics address Cardiac Arrest and Resuscitation, Trauma, Hemostasis, Coagulopathy, and Sepsis Diagnosis and Treatment, reflecting a clinical focus on critical and emergency care conditions.

Kuo has authored numerous publications across various scientific journals. Recent notable papers include:

  • "Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis" (2020, Critical Care)
  • "Infection in Advanced Chronic Kidney Disease and Subsequent Adverse Outcomes after Dialysis Initiation: A Nationwide Cohort Study" (2020, Scientific Reports)
  • "Diuretic effect of co-administration of furosemide and albumin in comparison to furosemide therapy alone: An updated systematic review and meta-analysis" (2021, PLoS ONE)
  • "Neutrophil-to-lymphocyte ratio is a marker for acute kidney injury progression and mortality in critically ill populations: a population-based, multi-institutional study" (2021, Journal of Nephrology)
  • "Incidence of Mortality, Acute Kidney Injury and Graft Loss in Adult Kidney Transplant Recipients with Coronavirus Disease 2019: Systematic Review and Meta-Analysis" (2021, Journal of Clinical Medicine)

Kuo frequently publishes in the following venues:

  • Scientific Reports
  • Journal of Clinical Medicine
  • PLoS ONE
  • Nutrients
  • Clinical Kidney Journal

Collaboration is an important aspect of Kuo's research, evident through repeated partnerships with other scientists. Frequent coauthors include:

  • Jia-Jin Chen
  • Chih-Hsiang Chang
  • Cheng-Chia Lee
  • Pei-Chun Fan
  • Chieh-Li Yen

The body of work represented by Kuo addresses clinically relevant questions in nephrology and related acute care fields, with significant contributions to understanding acute kidney injury progression, dialysis outcomes, and sepsis treatment protocols. Their systematic reviews and meta-analyses provide aggregated evidence on the efficacy of clinical markers and interventions related to kidney function and critical illness management.

Best Publications

  • Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

    Qui-Lim Choo;George Kuo;Amy J. Weiner;Lacy R. Overby

  • An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

    G. Kuo;Q.-L. Choo;H.J. Alter;G.L. Gitnick

  • Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis

    Harvey J. Alter;Robert H. Purcell;James W. Shih;Jacqueline C. Melpolder

  • A proposed system for the nomenclature of hepatitis C viral genotypes

    P Simmonds;A Alberti;H J Alter;F Bonino

  • Hepatitis C virus antibodies among risk groups in Spain.

    J.I. Esteban;L. Viladomiu;A. Gonzalez;M. Roget

  • Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease

    Michael Houghton;Amy Weiner;Jang Han;George Kuo

  • Detection of hepatitis C viral sequences in non-A, non-B hepatitis.

    A. J. Weiner;G. Kuo;D. W. Bradley;F. Bonino

  • PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA

    M. Colombo;Q.L. Choo;E. Del Ninno;N. Dioguardi

  • Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

    Q L Choo;A J Weiner;L R Overby;G Kuo

  • Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5' untranslated region and poly(A) tails at the 3' end.

    J H Han;V Shyamala;K H Richman;M J Brauer

  • T-lymphocyte response to hepatitis C virus in different clinical courses of infection

    Patrizia Botarelli;Maurizia R. Brunetto;Maria A. Minutello;Pierluigi Calvo

  • Hepatitis C Virus Infection in an Area Hyperendemic for Hepatitis B and Chronic Liver Disease: The Taiwan Experience

    Ding-Shinn Chen;George C. Kuo;Juei-Low Sung;Ming-Yang Lai

  • ANTI-HEPATITIS C ANTIBODIES AND NON-A, NON-B POST-TRANSFUSION HEPATITIS IN THE NETHERLANDS

    C.L. Van Der Poel;P.N. Lelie;Q-L. Choo;H.W. Reesink

  • A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan.

    Kusuya Nishioka;Junnosuke Watanabe;Seiichi Furuta;Eiji Tanaka

  • Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors.

    Cladd E. Stevens;Patricia E. Taylor;Johanna Pindyck;Qui-Lim Choo

  • Nanbv diagnostics and vaccines

    Michael Houghton;Qui-Lim Choo;George Kuo

  • Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers.

    James E. Everhart;Adrian M. Di Bisceglie;Linda M. Murray;Harvey J. Alter

  • Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma

    M.C. Kew;M. Houghton;Q.L. Choo;G. Kuo

  • Hepatitis C antibody and chronic liver disease in haemophilia

    M. Makris;F.E. Preston;D.R. Triger;J.C.E. Underwood

  • Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses.

    R. Ralston;K. Thudium;K. Berger;C. Kuo

Frequent Co-Authors

Michael Houghton
Michael Houghton University of Alberta
Tatsuo Miyamura
Tatsuo Miyamura National Institutes of Health
Daniel W. Bradley
Daniel W. Bradley Centers for Disease Control and Prevention
Izumu Saito
Izumu Saito University of Tokyo
Ferruccio Bonino
Ferruccio Bonino National Research Council (CNR)
Pablo Valenzuela
Pablo Valenzuela Novartis (United States)
Mickey S. Urdea
Mickey S. Urdea Halteres Associates
Chau-Ting Yeh
Chau-Ting Yeh Chang Gung Memorial Hospital
Yun-Fan Liaw
Yun-Fan Liaw Chang Gung Memorial Hospital
Jules L. Dienstag
Jules L. Dienstag Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying microbiology opens doors to various interdisciplinary career options. Many students complement their scientific background with public health knowledge. For those interested, there are online MPH programs easy to get into that offer flexible pathways to strengthen expertise in population health and disease prevention.

Beyond traditional microbiology roles, careers like child life specialists demonstrate how healthcare and emotional support combine. If you want to make a difference working with children facing medical challenges, learning how to become a child life specialist might be a meaningful path.

Students with diverse backgrounds, including those seeking second chances, can find hope in online educational programs. There are specialized college degrees for felons that help build skills and advance careers despite past challenges.

Health-focused practitioners can expand into emerging fields such as functional medicine. For microbiology graduates interested in holistic patient care, exploring functional medicine nurse practitioner programs provides innovative training that integrates science with personalized healing approaches.

Best Scientists Citing George Kuo